longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BOYA BIOLOGY

300294

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -115.70, below the reasonable range, cheaper than 98.61% of the time in the past 5 years, and the industry ranks 77/85, the industry Median 11.59.

-115.7xP/E
¥14.10Stock price
¥-0.12Earnings per share
-115.7xP/E
Stock price¥14.10Earnings per share¥-0.12

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
42.01x
Typical range
35.52x–75.58x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.59x
03978117156

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.59x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688180SHJunshi Biosciences
-76.21x92.53%¥33.59B
603392SHWantai Biological
-82.53x22.02%¥31.57B
300122SZZHIFEI-BIOL
-1.98x91.71%¥29.56B
688192SHDizal Pharmaceutical
-44.24x255.85%¥26.42B
300676SZBGI Genomics
-27.14x118.23%¥15.61B
688520SHSinocelltech
-17.30x171.21%¥15.52B
688765SHHEALTHGEN BIOTECH
-92.89x--¥12.83B
688062SHMabwell
-12.23x37.63%¥11.49B
688105SHVazyme
-1,244.74x770.82%¥10.93B
688319SHOlymvax Biopharmaceuticals
-455.14x227.87%¥10.84B
688382SHInventisBio
-32.30x5.45%¥10.80B
300204SZStaidson BioPharm
-118.03x--¥10.61B
688806SHTrinomab Pharmaceutical
-19.29x--¥9.85B
688759SHBeBetter Med
-54.13x12.50%¥9.61B
688443SHGenrix Bio
-14.64x32.19%¥8.24B
002030SZDAJY
-10.84x--¥7.40B
300294SZBOYA BIOLOGY
-115.70x281.82%¥7.11B
688137SHNovoprotein
-84.27x--¥6.97B
688177SHBIO-THERA
-15.10x2.47%¥6.93B
688488SHAidea Pharma
-1,107.71x--¥6.41B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.